Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers
Cancer Cell International,
Abstract Background Emerging evidence suggests that LMNB1 is involved in the development of multiple cancer types.